☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Research
Accelerating the Transition Between Antibody Research and Production
June 7, 2022
Moderna Entered into a Research and Development Collaboration with Metagenomi to Develop In Vivo Gene Editing Therapeutics
November 2, 2021
Antengene Enters into a Research Collaboration & License Option Agreement with LegoChem Biosciences for Antibody-Drug Conjugat...
October 21, 2021
Schr'dinger Signs a Two-Year Research Collaboration with MD Anderson to Advance its WEE1 Program
October 8, 2021
Genentech Signs a License Agreement with Adaptimmune to Develop and Commercialize Cancer-Targeted Allogeneic T-cell Therapies
September 8, 2021
NeuExcell Signs a Research Agreement with Spark to Develop a Novel Gene Therapy for Huntington's Disease
September 7, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.